GMABGenmab
Slide 1 of 3
Company Overview
Name
Genmab
52W High
$35.43
52W Low
$21.00
Market Cap
$18.5B
Dividend Yield
0%
Price/earnings
1.22
P/E
1.22
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$3.7B
Operating Revenue
$3.7B
Total Gross Profit
$3.5B
Total Operating Income
$1.1B
Net Income
$1B
EV to EBITDA
$17.04
EV to Revenue
$6.44
Price to Book value
$4.71
Price to Earnings
$19.21
Additional Data
Selling, General & Admin Expense
$626M
Research & Development Expense
$1.6B
Restructuring Charge
$185M
Total Operating Expenses
$-2.4B
Interest Expense
$-269M
Interest & Investment Income
$408M
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Genmab
52W High
$35.43
52W Low
$21.00
Market Cap
$18.5B
Dividend Yield
0%
Price/earnings
1.22
P/E
1.22
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$3.7B
Operating Revenue
$3.7B
Total Gross Profit
$3.5B
Total Operating Income
$1.1B
Net Income
$1B
EV to EBITDA
$17.04
EV to Revenue
$6.44
Price to Book value
$4.71
Price to Earnings
$19.21
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$626M
Research & Development Expense
$1.6B
Restructuring Charge
$185M
Total Operating Expenses
$-2.4B
Interest Expense
$-269M
Interest & Investment Income
$408M
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Jan G. J. van de Winkel
Location
N/A, Denmark
Exchange
Nasdaq
Website
https://genmab.com
Summary
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases.
Company Info
CEO
Jan G. J. van de Winkel
Location
N/A, Denmark
Exchange
Nasdaq
Website
https://genmab.com
Summary
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases.
AI Insights
Be the first to know. We'll notify you when AI insights for GMAB go live.
Community Research
Research from investors like you
Be the first to share your analysis on GMAB
Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.
Topics: Company overview • Products • Competitors • Strengths & Risks
Symbol's posts
No more topics to show